Related Experiment Video

Updated: Jun 15, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

[Immune system aging rate in patients with early forms of chronic cerebrovascular diseases]

N G Kochetkova, D Sh Al'tman, S N Teplova

    Advances in Gerontology = Uspekhi Gerontologii
    |March 10, 2010
    PubMed

    Insights

    This study diagnosed immune and cardiovascular aging rates in patients with early chronic cerebrovascular diseases (CCVD). Specific immune system aging patterns, including heterotropia and heterochronia, were identified in these patients.

    Area of Science:

    • Gerontology
    • Immunology
    • Cardiology
    • Neurology

    Background:

    • Chronic cerebrovascular diseases (CCVD) involve progressive damage to blood vessels in the brain.
    • Early detection of CCVD is crucial for timely intervention and management.
    • Aging processes significantly impact both the immune and cardiovascular systems.

    Purpose of the Study:

    • To diagnose the aging rate of the immune and cardiovascular systems in patients with early CCVD.
    • To investigate specific patterns of immune system aging in CCVD patients.
    • To compare age-dependent physiological changes with the general body aging rate.

    Main Methods:

    • Utilized Bioage and Snake software for diagnosing aging rates.
    • Assessed biological, cardiopulmonary, and immunological age indicators.
    • Studied patients with early cerebrovascular insufficiency and dyscirculatory encephalopathy (1st stage).

    Main Results:

    • Identified specific patterns of immune system aging in patients with early CCVD.
    • Verified cardinal aging symptoms, including heterotropia and heterochronia.
    • Diagnosed the rate of age-dependent physiological changes relative to general body aging.

    Conclusions:

    • Early forms of CCVD are associated with distinct immune system aging patterns.
    • The findings highlight the interplay between cerebrovascular health and systemic aging.
    • Further research can explore therapeutic strategies targeting these aging processes.

    More Related Videos

    Using Retinal Imaging to Study Dementia09:17

    Using Retinal Imaging to Study Dementia

    Published on: November 6, 2017

    Isolation and Characterization of the Immune Cells from Micro-dissected Mouse Choroid Plexuses09:55

    Isolation and Characterization of the Immune Cells from Micro-dissected Mouse Choroid Plexuses

    Published on: February 3, 2022

    Related Concept Videos

    Alzheimer Disease l: Introduction01:29

    Alzheimer Disease l: Introduction

    Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
    The Effect of Aging on Tissues01:19

    The Effect of Aging on Tissues

    Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
    Pharmacodynamics in Geriatric Patients: Effects of Age01:27

    Pharmacodynamics in Geriatric Patients: Effects of Age

    Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
    Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

    Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

    Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
    Aging01:26

    Aging

    Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
    Cellular Clock Theory
    The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
    Dementia l: Introduction01:22

    Dementia l: Introduction

    Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...